• Xeris Receives European Commission Approval of Ogluo for Hypoglycemia americanpharmaceuticalreview
    February 22, 2021
    Xeris Pharmaceuticals announced the European Commission (EC) has approved Ogluo™ (glucagon) injection for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.
PharmaSources Customer Service